未登录Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer's diseaseAL002的临床前期和首次人体评估,这是一种用于阿尔茨海默氏病的新型TREM2激动性抗体
Long, Hua; Simmons, Adam; Mayorga, Arthur; Burgess, Brady; Nguyen, Tuan; Budda, Balasubrahmanyam; Rychkova, Anna; Rhinn, Herve; Tassi, Ilaria; Ward, Michael; Yeh, Felix; Schwabe, Tina; Paul, Robert; Kenkare-Mitra, Sara; Rosenthal, Arnon
分享
收藏ADJUDICATION PROCESS FOR JOINT EVENTS OF INTEREST IN FULRANUMAB CLINICAL TRIAL PROGRAM
Moskowitz, R.; Brandt, K.; Lequesne, M.; Mont, M. A.; Kneeland, B.; Sange, P.; Mayorga, A.; Kelly, K. M.; Upmalis, D.; Thipphawong, J.; Pierce, P.
分享
收藏Safety and efficacy of galantamine in subjects with mild cognitive impairment
Winblad, B.; Gauthier, S.; Scinto, L.; Feldman, H.; Wilcock, G. K.; Truyen, L.; Mayorga, A. J.; Wang, D.; Brashear, H. R.; Nye, J. S.
分享
收藏Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations
Bowyer, JF; Young, JF; Slikker, W; Itzak, Y; Mayorga, AJ; Newport, GD; Ali, SF; Frederick, DL; Paule, MG
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏